171 related articles for article (PubMed ID: 28347253)
1. Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells.
Yang P; Li B; Yin QF; Wang YJ
Tumour Biol; 2017 Mar; 39(3):1010428317692267. PubMed ID: 28347253
[TBL] [Abstract][Full Text] [Related]
2. The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells
Wang Y; Jiang L; Yin Q; Liu H; Liu G; Zhu G; Li B
J Cancer; 2017; 8(15):3001-3013. PubMed ID: 28928892
[TBL] [Abstract][Full Text] [Related]
3. Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency.
Wang J; Chen B; Zhao D; Peng Y; Zhuo RX; Cheng SX
Int J Pharm; 2013 Mar; 446(1-2):205-10. PubMed ID: 23422273
[TBL] [Abstract][Full Text] [Related]
4. A pH-Sensitive Nanosystem Based on Carboxymethyl Chitosan for Tumor-Targeted Delivery of Daunorubicin.
Zhang X; Zhang H; Yin L; Hu R; Qiu T; Yin Y; Xiong X; Zheng H; Wang Q
J Biomed Nanotechnol; 2016 Aug; 12(8):1688-98. PubMed ID: 29342347
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells.
Maya S; Kumar LG; Sarmento B; Sanoj Rejinold N; Menon D; Nair SV; Jayakumar R
Carbohydr Polym; 2013 Apr; 93(2):661-9. PubMed ID: 23499109
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of inhibitory effects of C-phycocyanin combined with all-trans-retinoic acid on the growth of HeLa cells in vitro.
Yang F; Li B; Chu XM; Lv CY; Xu YJ; Yang P
Tumour Biol; 2014 Jun; 35(6):5619-28. PubMed ID: 24563337
[TBL] [Abstract][Full Text] [Related]
8. Screening of novel RGD peptides to modify nanoparticles for targeted cancer therapy.
Ge L; You X; Huang K; Kang Y; Chen Y; Zhu Y; Ren Y; Zhang Y; Wu J; Qian H
Biomater Sci; 2017 Dec; 6(1):125-135. PubMed ID: 29142995
[TBL] [Abstract][Full Text] [Related]
9. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.
Mahjub R; Heidari Shayesteh T; Radmehr M; Vafaei SY; Amini M; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2016; 21(1):14-25. PubMed ID: 25255172
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
11. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect.
Rana S; Datta K; Reddy TL; Chatterjee E; Sen P; Pal-Bhadra M; Bhadra U; Pramanik A; Pramanik P; Chawla-Sarkar M; Sarkar S
J Control Release; 2015 Feb; 200():167-78. PubMed ID: 25575863
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
13. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier.
Yostawonkul J; Surassmo S; Iempridee T; Pimtong W; Suktham K; Sajomsang W; Gonil P; Ruktanonchai UR
Colloids Surf B Biointerfaces; 2017 Jan; 149():301-311. PubMed ID: 27780087
[TBL] [Abstract][Full Text] [Related]
14. Polyelectrolyte complex of carboxymethyl gum katira-chitosan: Preparation and characterization.
Minkal ; Ahuja M; Bhatt DC
Int J Biol Macromol; 2018 Jan; 106():1184-1191. PubMed ID: 28851639
[TBL] [Abstract][Full Text] [Related]
15. O-carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells.
Snima KS; Jayakumar R; Unnikrishnan AG; Nair SV; Lakshmanan VK
Carbohydr Polym; 2012 Jul; 89(3):1003-7. PubMed ID: 24750892
[TBL] [Abstract][Full Text] [Related]
16. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
[TBL] [Abstract][Full Text] [Related]
17. Amidase encapsulated O-carboxymethyl chitosan nanoparticles for vaccine delivery.
Smitha KT; Sreelakshmi M; Nisha N; Jayakumar R; Biswas R
Int J Biol Macromol; 2014 Feb; 63():154-7. PubMed ID: 24211432
[TBL] [Abstract][Full Text] [Related]
18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
